Skip to main content
. 2004 Nov 15;114(10):1444–1456. doi: 10.1172/JCI21689

Figure 7.

Figure 7

Effect of systemic (Syst.) treatment with a PAR1 antagonist on survival rate (A), MPO activity (B and F), body weight (C and G), macroscopic- and microscopic-damage score (D, E, and H), and disease activity (I) in BALB/c mice, 7 days after the induction of colitis by intracolonic administration of TNBS at the dose of 2 mg per mouse in 50% ethanol (A and B) or at the dose of 1 mg/kg in 50% ethanol (CF), or 8 days after the induction of DSS colitis (GI). Values are mean ± SEM; n = 12 per group. *Significantly different from naive group; **significantly different from vehicle-treated group.

HHS Vulnerability Disclosure